Actively Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Led by University Hospital, Lille · Updated on 2026-05-05
2200
Participants Needed
1
Research Sites
574 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Lille
Lead Sponsor
F
FHU IMMINeNT
Collaborating Sponsor
AI-Summary
What this Trial Is About
Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with professional, social and emotional repercussions. Beyond this burden, IMIDs share many common pathophysiological mechanisms and treatments, known as "targeted therapies". Despite progress in this field, much remains to be done in clinical, therapeutic and fundamental research to address the efficacy, resistance and side-effects of treatment. These similarities between IMIDs have led the FHU IMMINeNT to propose the creation of a prospective, multidisciplinary clinical-biological database (IMMINeNT cohort), associated to a biobank, of patients with IMIDs. The main objectives of this database will be to identify new prognostic and therapeutic biomarkers in order to develop new therapeutic targets and biomarkers, to identify prognostic factors and determinants related to the activity, severity and quality of life of patients with IMIDs as well as to the response and tolerance to treatment.
CONDITIONS
Official Title
Deployment o the Multidisciplinary Prospective Cohort Imminent
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient followed for their IMID in one of the departments of the Lille University Hospital participating in the study (dermatology, internal medicine, neurology, pneumology and rheumatology)
- Social insured
- Have the capacity to understand the study requirements, provide written informed consent, and comply with the study data collection procedures.
You will not qualify if you...
- Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system.
- Pregnant or breastfeeding woman
- Persons deprived of liberty
- Protected minors or adults
- Persons who have refused or are incapable of giving informed consent
- Persons in Emergency Situations
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hop Claude Huriez Chu Lille
Lille, France, 59037
Actively Recruiting
Research Team
D
David Launay, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here